Wedbush reiterates Tesla stock Outperform rating at $600 target By Investing.com

Tesla trades at $372.11 (market cap $1.4T) with a P/E of 345.54 and InvestingPro flags the stock as overvalued versus fair value. Wedbush reiterated Outperform with a $600 price target and reiterated a view that Tesla and SpaceX could merge by 2027; Tesla also announced two advanced AI-focused chip fabs in Austin and a joint Terafab facility with SpaceX. Analyst views diverge—RBC Outperform $500 PT and Q1'26 delivery estimate 367,000 (vs 369,000 consensus), Barclays Equalweight $360 PT noting capex could exceed $20B, and GLJ downgraded to Sell with a $25.28 PT after the NHTSA upgraded its probe to an Engineering Analysis covering ~3.2M vehicles—heightening regulatory risk and near-term volatility.

Analysis

Consolidating high-end compute and vehicle hardware under a single control structure creates a binary capital-allocation and regulatory showdown: investors are effectively long both a consumer hardware business and a strategic aerospace/compute asset at once, which makes valuation multiples more sensitive to control, carve-up, or divestiture outcomes than to unit economics. That increases event risk and compresses the effective time horizon for realizing value from AI investments — what would normally be a multi-year hardware cycle becomes a 12–36 month political and antitrust binary.

A push to internalize advanced compute capacity materially shifts demand away from external foundries, packaging houses and captive-server buyers; this is a two-edged sword — it can lift specialist system integrators and AI-server vendors while reducing addressable market for traditional third-party silicon supply chains. On the demand side, incremental in-house capacity is likely to substitute high-margin external orders first (near-term), with only modest effect on end-market device volumes for competitors until multi-year capacity reconfiguration completes.

Regulatory and safety scrutiny are the highest-probability near-term catalysts for volatility, with outcomes that can change sentiment within weeks (bad headlines/recalls) or years (antitrust remedies). Conversely, successful captive chip execution would re-rate margins and systematically lower opex per unit, but that outcome requires multiple milestones (tool installs, yields, qualified stack) over 12–36 months and is far from guaranteed.

Consensus tends to treat the corporate-combination story as optional upside rather than a central valuation lever; that understates the downside asymmetry around regulatory/balance-sheet risk. For investors who want exposure to the AI compute wave without concentrated governance and regulatory binary, there are cleaner infrastructure proxies and hedges offering more favorable risk/reward than owning the integrated conglomerate outright.

Key Decisions for Investors

• Pair trade (3–12 months): Long SMCI 5% portfolio, short TSLA 7.5% portfolio (size short to approximate delta exposure). Rationale: capture secular AI hardware demand while hedging headline-driven equity risk in the integrated mobility/compute name. Target: +25–40% on the pair if compute demand re-rates; max loss ~15% if both rally in a risk-on squeeze.
• Options hedge on TSLA (6–12 months): Buy a put spread ~15–25% OTM (buy nearer leg, sell deeper leg) sized to cover equity risk for 3–6 months of earnings/delivery windows. Cost financed by the sold leg keeps premium low; max payout kicks in if stock trades down 40%+, offering asymmetric protection vs cost of carry.
• Event-driven long SMCI call spread (12 months): Buy 1x 30–50% OTM call spread to play accelerated AI server demand and capacity buildouts. Limited debit risk (premium) with 2–4x upside if SMCI captures outsized OEM refresh cycles tied to new fabs/systems.
• Tactical long APP (6–12 months), small position (1–2% portfolio): Exposure to software-driven monetization and AI-driven ad yield improvements that are less exposed to hardware or regulatory headlines. Target 30–50% upside if ad yields and LTV metrics improve; downside capped to standard equity drawdowns.
• Maintain small cash/volatility buffer (5%): Hold dry powder or short-dated IV via strangles to deploy into headline-driven selloffs around regulatory actions or safety developments — these are the most likely windows to add asymmetric risk positions at cheaper prices.